login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
GOSSAMER BIO INC (GOSS) Stock News
USA
-
Nasdaq
- NASDAQ:GOSS -
US38341P1021
-
Common Stock
3.79
USD
+0.19 (+5.28%)
Last: 12/15/2025, 8:00:02 PM
3.8596
USD
+0.07 (+1.84%)
Pre-Market:
12/16/2025, 8:00:03 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
GOSS Latest News, Press Relases and Analysis
All
Press Releases
7 days ago - By: Gossamer Bio, Inc.
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
22 days ago - By: Gossamer Bio, Inc.
Gossamer Bio to Participate in Upcoming Investor Conferences
a month ago - By: Gossamer Bio, Inc.
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
7 months ago - By: Benzinga
Exploring Gossamer Bio's Earnings Expectations
a month ago - By: Gossamer Bio, Inc.
Gossamer Bio to Participate in Upcoming Investor Conferences
a month ago - By: Zacks Investment Research
- Mentions:
MGTX
Gossamer Bio (GOSS) Reports Q3 Loss, Tops Revenue Estimates
a month ago - By: Gossamer Bio, Inc.
Gossamer Bio Announces Third Quarter 2025 Financial Results and Provides Business Update
3 months ago - By: Respira Therapeutics, Inc.
Respira Therapeutics Enters into Agreement with Gossamer Bio (Gossamer) Granting Gossamer Option to Acquire Respira from Samsara BioCapital
3 months ago - By: Gossamer Bio, Inc.
Gossamer Bio Enters into Option Agreement to Acquire Respira Therapeutics and Its Lead Candidate, RT234, an Inhaled, On‑Demand Vardenafil for Pulmonary Hypertension
3 months ago - By: Gossamer Bio, Inc.
Gossamer Bio Announces Presentations at the European Respiratory Society (ERS) Congress 2025
3 months ago - By: Gossamer Bio, Inc.
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
3 months ago - By: Benzinga
- Mentions:
SAIA
HPQ
NEM
NKE
This Saia Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
4 months ago - By: Gossamer Bio, Inc.
Gossamer Bio to Present at Upcoming Investor Conferences
4 months ago - By: Gossamer Bio, Inc.
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
4 months ago - By: Zacks Investment Research
- Mentions:
VSTM
Gossamer Bio (GOSS) Reports Q2 Loss, Beats Revenue Estimates
4 months ago - By: Gossamer Bio, Inc.
Gossamer Bio Announces Second Quarter 2025 Financial Results and Provides Business Update
4 months ago - By: Zacks Investment Research
- Mentions:
HRMY
Harmony Biosciences Holdings, Inc. (HRMY) Misses Q2 Earnings and Revenue Estimates
6 months ago - By: Gossamer Bio, Inc.
Gossamer Bio Announces Completion of Enrollment in Registrational Phase 3 PROSERA Study for the Treatment of PAH
6 months ago - By: Stocktwits
- Mentions:
TNMG
RGBP
BIXT
WYTC
...
Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream
6 months ago - By: Gossamer Bio, Inc.
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
7 months ago - By: Zacks Investment Research
- Mentions:
ROIV
Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates
7 months ago - By: Gossamer Bio, Inc.
Gossamer Bio Announces First Quarter 2025 Financial Results and Provides Business Update, Including Closure of New Patient Screening in Phase 3 PROSERA Study
7 months ago - By: Yahoo Finance
- Mentions:
PYPL
FTA to defend open banking in court
7 months ago - By: Gossamer Bio, Inc.
Gossamer Bio to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15, 2025
7 months ago - By: Gossamer Bio, Inc.
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
7 months ago - By: Gossamer Bio, Inc.
Gossamer Bio to Present Preclinical Data at the American Thoracic Society (ATS) 2025 International Conference
8 months ago - By: Yahoo Finance
- Mentions:
DB
BTU
EQH
NVDA
...
Peabody pauses seeking debt for partial refinance of $2.1bn private loan
8 months ago - By: Yahoo Finance
- Mentions:
GERN
CAN
GILD
NUVB
...
Is Geron Corp. (NASDAQ:GERN) the Best Biotech Penny Stock to Buy According to Hedge Funds?
8 months ago - By: Yahoo Finance
- Mentions:
ECX
CAN
AIG
PLTR
...
Is Ecarx Holdings Inc. (NASDAQ:ECX) the Best Penny Stock to Invest in Under $1?
8 months ago - By: Yahoo Finance
- Mentions:
ALSN
CAN
NUVB
BTU
...
Is Gossamer Bio Inc. (NASDAQ:GOSS) the Best Penny Stock to Invest in Under $1?
8 months ago - By: Yahoo Finance
- Mentions:
COIN
AMD
DG
NVDA
...
Coinbase price target lowered to $275 from $390 at Monness Crespi
8 months ago - By: Yahoo Finance
- Mentions:
RLAY
KIND
DAWN
BG
...
Relay Therapeutics, Inc. (RLAY): Among Stocks Under $10 that Will Triple
8 months ago - By: Yahoo Finance
- Mentions:
PRLD
DAWN
VIR
NUVB
...
Gossamer Bio, Inc. (GOSS): Among Stocks Under $10 that Will Triple
8 months ago - By: Yahoo Finance
- Mentions:
NUVB
RLAY
TSLA
DAWN
...
Nuvation Bio Inc. (NUVB): Among Stocks Under $10 that Will Triple
8 months ago - By: Yahoo Finance
- Mentions:
NTLA
NUVB
IBRX
VSAT
...
Intellia Therapeutics, Inc. (NTLA): Among Stocks Under $10 that Will Triple
8 months ago - By: Yahoo Finance
- Mentions:
PLTR
COMP
MRVL
AJG
...
1 Artificial Intelligence (AI) Growth Stock That Could Soar Thanks to Trump's Tariffs
8 months ago - By: Gossamer Bio, Inc.
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
9 months ago - By: Gossamer Bio, Inc.
Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
Please enable JavaScript to continue using this application.